CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury

Journal of Neuroscience

Volumn 28, Issue 18, 2008, Pages 4661-4670

  Kim, Eunhee ^a   Tolhurst, Aaron T ^a   Lu, Ye Qin ^a   Chen, Xin Yuan ^a   Febbraio, Maria ^b   Cho, Sunghee ^a,c  

^a BURKE MEDICAL RESEARCH INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CD36; Foam cell formation; Inflammation; Ischemia; Macrophage; Stroke

Indexed keywords

APOLIPOPROTEIN E; CD36 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; ABC TRANSPORTER; ABCG1 PROTEIN, MOUSE; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2; CHOLESTEROL; CYTOKINE; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE EXACERBATION; GENE DELETION; GENE EXPRESSION; HYPERLIPIDEMIA; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STROKE; ANIMAL; BLOOD; BODY WEIGHT; BRAIN EDEMA; BRAIN INFARCTION; C57BL MOUSE; CELL COUNT; CEREBRAL ARTERY DISEASE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BODY WEIGHT; BRAIN EDEMA; BRAIN INFARCTION; CELL COUNT; CHEMOKINE CCL2; CHOLESTEROL; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERLIPIDEMIAS; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPOPROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CCR2;

EID: 44649087184     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0982-08.2008     Document Type: Article

References (48)

1. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268:17665-17668.
2. Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819-834.
3. Becker KJ (1998) Inflammation and acute stroke. Curr Opin Neurol 11:45-49.
4. Chen Y, Hallenbeck JM, Ruetzler C, Bol D, Thomas K, Berman NE, Vogel SN (2003) Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 23:748-755.
5. Cho S, Park EM, Febbraio M, Anrather J, Park L, Racchumi G, Silverstein RL, Iadecola C (2005) The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J Neurosci 25:2504-2512.
6. Cho S, Szeto HH, Kim E, Kim H, Tolhurst AT, Pinto JT (2007) A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem 282:4634-4642.
7. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95-112.
8. de Winther MP, van Dijk KW, Havekes LM, Hofker MH (2000) Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 20:290-297.
9. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV (2007) Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38:1345-1353.
10. El Khoury JB, Moore KJ, Means TK, Leung J, Terada K, Toft M, Freeman MW, Luster AD (2003) CD36 mediates the innate host response to beta-amyloid. J Exp Med 197:1657-1666.
11. Elkind MS (2006) Inflammation, atherosclerosis, and stroke. Neurologist 12:140-148.
12. Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F (2002) Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 105:2632-2637.
13. Engström G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, Lindgärde F (2003) Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes 52:442-447.
14. Evans M, Roberts A, Davies S, Rees A (2004) Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Drugs 64:1181-1196.
15. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL (1999) A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274:19055-19062.
16. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105:1049-1056.
17. Febbraio M, Hajjar DP, Silverstein RL (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785-791.
18. Febbraio M, Guy E, Silverstein RL (2004) Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol 24:2333-2338.
19. Griffin E, Re A, Hamel N, Fu C, Bush H, McCaffrey T, Asch AS (2001) A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat Med 7:840-846.
20. Guy E, Kuchibhotla S, Silverstein R, Febbraio M (2007) Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o/apoEo mice. Atherosclerosis 192:123-130.
21. Han KH, Han KO, Green SR, Quehenberger O (1999) Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function. J Lipid Res 40:1053-1063.
22. Hirano K, Kuwasako T, Nakagawa-Toyama Y, Janabi M, Yamashita S, Matsuzawa Y (2003) Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med 13:136-141.
23. Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66:232-245.
24. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C (2002) Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 22:308-317.
25. Hutter CM, Austin MA, Humphries SE (2004) Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am J Epidemiol 160:430-435.
26. Iadecola C, Alexander M (2001) Cerebral ischemia and inflammation. Curr Opin Neurol 14:89-94.
27. Iadecola C, Cho S, Feuerstein GZ, Hallenbeck J (2004) Cerebral ischemia and inflammation. In: Stroke: pathophysiology, diagnosis, and management, pp 883-894. Philadelphia: Churchill Livingstone.
28. Janabi M, Yamashita S, Hirano K, Sakai N, Hiraoka H, Matsumoto K, Zhang Z, Nozaki S, Matsuzawa Y (2000) Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol 20:1953-1960.
29. Kernan WN, Inzucchi SE (2004) Type 2 diabetes mellitus and insulin resistance: stroke prevention and management. Curr Treat Options Neurol 6:443-450.
30. Kochanek PM, Hallenbeck JM (1992) Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23:1367-1379.
31. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27:2596-2605.
32. Liang CP, Han S, Okamoto H, Carnemolla R, Tabas I, Accili D, Tall AR (2004) Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 113:764-773.
33. Lin TN, He YY, Wu G, Khan M, Hsu CY (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24:117-121.
34. Medeiros LA, Khan T, El Khoury JB, Pham CL, Hatters DM, Howlett GJ, Lopez R, O'Brien KD, Moore KJ (2004) Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J Biol Chem 279:10643-10648.
35. Moore KJ, Freeman MW (2006) Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26:1702-1711.
36. Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM, McKee M, Freeman MW (2005) Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 115:2192-2201.
37. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204:3037-3047.
38. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133-140.
39. Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G (2004) Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med 4:287-303.
40. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Gugiu B, Fox PL, Hoff HF, Salomon RG, Hazen SL (2002a) Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 277:38503-38516.
41. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL (2002b) A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem 277:38517-38523.
42. Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL (2007) Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 13:1086-1095.
43. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL (2006) A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 4:211-221.
44. Savill J (1997) Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 53:491-508.
45. Strandgaard S (1996) Hypertension and stroke. J Hypertens Suppl 14:S23-S27.
46. Stuart LM, Bell SA, Stewart CR, Silver JM, Richard J, Goss JL, Tseng AA, Zhang A, El Khoury JB, Moore KJ (2007) CD36 signals to the actin cytoskeleton and regulates microglial migration via a p130Cas complex. J Biol Chem 282:27392-27401.
47. Tabata T, Mine S, Kawahara C, Okada Y, Tanaka Y (2003) Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells. Biochem Biophys Res Commun 305:380-385.
48. Willerson JT, Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109:II2-II10.